News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CeMines Inc. Licenses Lung Cancer IP to Ortho-Clinical Diagnostics


12/9/2008 11:36:30 AM

GOLDEN, CO--(Marketwire - December 09, 2008) - CeMines, Inc., a developer of innovative solutions for early stage detection of cancer, today announced it has entered into an agreement with Raritan, N.J.-based Ortho Clinical Diagnostics ("OCD") to license certain CeMines Intellectual Property relating to blood-based testing for early stage lung cancer.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES